These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 24295134

  • 1. Use of density functional theory in drug metabolism studies.
    Rydberg P, Jørgensen FS, Olsen L.
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
    [Abstract] [Full Text] [Related]

  • 2. Prediction of cytochrome P450 mediated metabolism.
    Olsen L, Oostenbrink C, Jørgensen FS.
    Adv Drug Deliv Rev; 2015 Jun 23; 86():61-71. PubMed ID: 25958010
    [Abstract] [Full Text] [Related]

  • 3. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
    Lewis DF, Ito Y.
    Expert Opin Drug Metab Toxicol; 2010 Jun 23; 6(6):661-74. PubMed ID: 20402561
    [Abstract] [Full Text] [Related]

  • 4. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ.
    Drug Discov Today; 2006 Jul 23; 11(13-14):601-6. PubMed ID: 16793528
    [Abstract] [Full Text] [Related]

  • 5. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D, Wu B, Chow D, Hu M.
    Drug Metab Rev; 2012 May 23; 44(2):192-208. PubMed ID: 22251142
    [Abstract] [Full Text] [Related]

  • 6. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF, Jacobs MN, Dickins M.
    Drug Discov Today; 2004 Jun 15; 9(12):530-7. PubMed ID: 15183161
    [Abstract] [Full Text] [Related]

  • 7. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D, Wu B.
    Drug Metab Rev; 2012 Feb 15; 44(1):1-17. PubMed ID: 22242930
    [Abstract] [Full Text] [Related]

  • 8. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
    Tarcsay Á, Keseru GM.
    Expert Opin Drug Metab Toxicol; 2011 Mar 15; 7(3):299-312. PubMed ID: 21291341
    [Abstract] [Full Text] [Related]

  • 9. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
    Liu R, Liu J, Tawa G, Wallqvist A.
    J Chem Inf Model; 2012 Jun 25; 52(6):1698-712. PubMed ID: 22631565
    [Abstract] [Full Text] [Related]

  • 10. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF, Ito Y, Goldfarb PS.
    Curr Med Chem; 2006 Jun 25; 13(22):2645-52. PubMed ID: 17017916
    [Abstract] [Full Text] [Related]

  • 11. The valence bond way: reactivity patterns of cytochrome P450 enzymes and synthetic analogs.
    Shaik S, Lai W, Chen H, Wang Y.
    Acc Chem Res; 2010 Aug 17; 43(8):1154-65. PubMed ID: 20527755
    [Abstract] [Full Text] [Related]

  • 12. A pragmatic approach using first-principle methods to address site of metabolism with implications for reactive metabolite formation.
    Hsiao YW, Petersson C, Svensson MA, Norinder U.
    J Chem Inf Model; 2012 Mar 26; 52(3):686-95. PubMed ID: 22299574
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
    Murray M.
    Int J Mol Med; 1999 Mar 26; 3(3):227-38. PubMed ID: 10028046
    [Abstract] [Full Text] [Related]

  • 14. The impact of carbon-hydrogen bond dissociation energies on the prediction of the cytochrome P450 mediated major metabolic site of drug-like compounds.
    Drew KL, Reynisson J.
    Eur J Med Chem; 2012 Oct 26; 56():48-55. PubMed ID: 22960693
    [Abstract] [Full Text] [Related]

  • 15. In vitro approaches to investigate cytochrome P450 activities: update on current status and their applicability.
    Ong CE, Pan Y, Mak JW, Ismail R.
    Expert Opin Drug Metab Toxicol; 2013 Sep 26; 9(9):1097-113. PubMed ID: 23682848
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 (CYP) enzymes and the development of CYP biosensors.
    Schneider E, Clark DS.
    Biosens Bioelectron; 2013 Jan 15; 39(1):1-13. PubMed ID: 22809523
    [Abstract] [Full Text] [Related]

  • 17. Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and limitations.
    Lohmann W, Karst U.
    Anal Bioanal Chem; 2008 May 15; 391(1):79-96. PubMed ID: 18163163
    [Abstract] [Full Text] [Related]

  • 18. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.
    McGinnity DF, Griffin SJ, Moody GC, Voice M, Hanlon S, Friedberg T, Riley RJ.
    Drug Metab Dispos; 1999 Sep 15; 27(9):1017-23. PubMed ID: 10460801
    [Abstract] [Full Text] [Related]

  • 19. Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs.
    Öeren M, Walton PJ, Hunt PA, Ponting DJ, Segall MD.
    J Comput Aided Mol Des; 2021 Apr 15; 35(4):541-555. PubMed ID: 32533369
    [Abstract] [Full Text] [Related]

  • 20. Fast prediction of cytochrome P450 mediated drug metabolism.
    Rydberg P, Vasanthanathan P, Oostenbrink C, Olsen L.
    ChemMedChem; 2009 Dec 15; 4(12):2070-9. PubMed ID: 19852016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.